WHO Raises Alarm Over Fake Ozempic Drugs: Health Risks and Safety Alerts

The World Health Organization (WHO) issued a global alert addressing the distribution of counterfeit Ozempic, a diabetes drug also used for weight loss. The WHO underscores the serious health risks of these fake drugs, which may lack the active ingredient semaglutide or contain harmful substances. The alert follows an increase in reports of falsified Ozempic and advises sourcing from reputable providers only.

Understanding the Link Between PMDD and Postpartum Depression

This insightful article explores the connection between Premenstrual Dysphoric Disorder (PMDD) and Postpartum Depression. It delves into the symptoms, underlying causes, and potential treatments, offering valuable information for women who may be experiencing these conditions. Readers will also find tips for managing symptoms and improving mental health.